NICE Submission Workflow

The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

NICE 2025 requirements

NICE (2025) Methods Support Document (PMG36) on health inequalities requires manufacturers to submit DCEA as supplementary evidence when:

The intervention targets a condition with documented SES gradients.
The ICER is above £20,000/QALY and equity may affect the decision.
The committee requests equity evidence.

Step-by-step NICE workflow

1. Determine method

Use aggregate DCEA unless subgroup-specific evidence is available.

# Check whether disease has SES gradient
# Use disease_icd to auto-lookup HES utilisation
result <- run_aggregate_dcea(
  icer            = 28000,
  inc_qaly        = 0.45,
  inc_cost        = 12600,
  population_size = 12000,
  disease_icd     = "C34",
  wtp             = 20000,
  opportunity_cost_threshold = 13000
)

2. Sensitivity analysis

NICE expects sensitivity over key parameters, especially η.

sa <- run_dcea_sensitivity(result, params_to_vary = c("eta", "wtp", "occ_threshold"))
sa$eta_profile
#> # A tibble: 11 × 5
#>      eta equity_weight_q1 equity_weight_q5 equity_weighted_nhb delta_ede
#>    <int>            <dbl>            <dbl>               <dbl>     <dbl>
#>  1     0             1               1                  -1246.    -0.104
#>  2     1             1.14            0.886              -1265.    -0.106
#>  3     2             1.28            0.779              -1284.    -0.108
#>  4     3             1.43            0.680              -1303.    -0.110
#>  5     4             1.59            0.589              -1322.    -0.112
#>  6     5             1.75            0.506              -1340.    -0.114
#>  7     6             1.92            0.432              -1358.    -0.116
#>  8     7             2.09            0.366              -1374.    -0.118
#>  9     8             2.25            0.308              -1390.    -0.119
#> 10     9             2.42            0.258              -1405.    -0.121
#> 11    10             2.58            0.215              -1419.    -0.122

3. Generate submission table

tbl <- generate_nice_table(result, format = "tibble")
knitr::kable(tbl, caption = "DCEA Summary Table (NICE format)")

DCEA Summary Table (NICE format)
Equity subgroup	Baseline HALE (years)	Post-intervention HALE (years)	Change in HALE (years)	Net Health Benefit (QALYs)	Population share
Q1 (most deprived)	52.1	51.97	-0.1298	-1557.69	0
Q2	56.3	56.18	-0.1168	-1401.92	0
Q3	59.8	59.70	-0.1038	-1246.15	0
Q4	63.2	63.11	-0.0909	-1090.38	0
Q5 (least deprived)	66.8	66.72	-0.0779	-934.62	0
Total / Summary	NA	NA	NA	-6230.77	1.000

4. Export to Excel

export_dcea_excel(result, "dcea_submission.xlsx")

5. Present impact plane

plot_equity_impact_plane(result)

NICE compliance checklist

Aggregate DCEA conducted using England IMD quintile baseline
Opportunity cost threshold set to £13,000/QALY
Sensitivity analysis over η range 0-10
Equity-efficiency impact plane included
SII, RII, and Atkinson index reported pre and post
NICE submission table generated
Results presented as supplementary to base-case CEA

References

NICE (2025). Technology Evaluation Methods: Health Inequalities (PMG36). National Institute for Health and Care Excellence.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.